Ovarian Cancer Awareness Month Draws Attention to Uneven Declines in Mortality
Contributor: Why US Health Care Is Ripe for Change
FDA Approves Once-Weekly Dosing for Lecanemab-irmb to Treat Early Alzheimer Disease
NOTCH1 Levels Impact Immune Response in SCLC
New Executive Order Shifts Homeless Policy, Potentially Overwhelming Health Care Services: A Q&A With Kristen R. Choi, PhD, PMHNP-BC, FAAN
Q&A Part 1: Improving Oral Health Through Education and Outreach With UPMC Health Plan Dental Care Managers
The Totality of Evidence of Ustekinumab Biosimilar SB17
Immune Profiling May Help Gauge Infection Risk in Patients With CLL
Neoadjuvant Immunotherapy Plus Chemotherapy Shows Promise in LS-SCLC
International Overdose Awareness Day: Bridging Gaps in Overdose Recovery Care
Rheumatoid Arthritis Associated With Increased Risk of IPF
Rilzabrutinib Becomes First FDA-Approved BTK Inhibitor for ITP
Eligibility Confusion, Constant Changes in Medicaid Could Leave Children Behind: Chris Johnson, MBA
Rurality, Long Travel Times Limit Access to Tobacco Treatment for Patients With COPD Who Smoke
Smoking Remains a Major Driver of Rheumatoid Arthritis Burden Worldwide
Managing Opioid Use Disorder Through Collaborative Care
Iron Dysregulation and Ferroptosis as Novel Targets in Pulmonary Fibrosis
Camrelizumab Plus Carboplatin, Nab-Paclitaxel Shows Efficacy in ES-SCLC
Echocardiographic Assessment Shows Promise as Risk Predictor in PAH
Long-Term Data Reinforce Givinostat Efficacy, Safety in DMD
ART Adherence Linked to Patient-Centered Care From Patient-Provider Relationships
Mediterranean Diet and Exercise Improve Outcomes in MASLD, MASH
Gene Therapy Meaningfully Improves Quality of Life in Severe Sickle Cell Disease
Medicaid Expansion's Unfinished Map: Some Southern States Still at a Crossroads
Eligibility, Enrollment Potential Barriers to Children Receiving Medicaid After Cuts: Chris Johnson, MBA
5 Types of Vaccine Technology
Executive Order Regarding Homelessness Does Not Address Root Causes
Interval Cytoreductive Surgery Following Neoadjuvant Chemotherapy Improves Advanced Ovarian Cancer Outcomes
Real-World Data Support Safety, Efficacy of Venetoclax for CLL
ADAPT SERON Trial Shows Positive Results for Seronegative gMG